PCN5 ANALYSIS OF OVER 2400 MODERN PHASE I CANCER TRIALS- COMPOSITION, OUTCOMES, AND USE OF SURROGATE ENDPOINTS
May 1, 2004, 00:00
10.1016/S1098-3015(10)62147-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)62147-X/fulltext
Title :
PCN5 ANALYSIS OF OVER 2400 MODERN PHASE I CANCER TRIALS- COMPOSITION, OUTCOMES, AND USE OF SURROGATE ENDPOINTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62147-X&doi=10.1016/S1098-3015(10)62147-X
First page :
Section Title :
Open access? :
No
Section Order :
87